- Home
- LNW vs GH Comparison
LNW vs GH Comparison
Compare LNW & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNW
- GH
- Stock Information
- Founded
- LNW 1984
- GH 2011
- Country
- LNW United States
- GH United States
- Employees
- LNW N/A
- GH N/A
- Industry
- LNW EDP Services
- GH Medical Specialities
- Sector
- LNW Technology
- GH Health Care
- Exchange
- LNW Nasdaq
- GH Nasdaq
- Market Cap
- LNW 6.9B
- GH 5.5B
- IPO Year
- LNW N/A
- GH 2018
- Fundamental
- Price
- LNW $81.49
- GH $41.72
- Analyst Decision
- LNW Buy
- GH Strong Buy
- Analyst Count
- LNW 12
- GH 21
- Target Price
- LNW $109.08
- GH $52.81
- AVG Volume (30 Days)
- LNW 1.2M
- GH 2.7M
- Earning Date
- LNW 05-07-2025
- GH 04-30-2025
- Dividend Yield
- LNW N/A
- GH N/A
- EPS Growth
- LNW 56.05
- GH N/A
- EPS
- LNW 3.74
- GH N/A
- Revenue
- LNW $3,206,000,000.00
- GH $773,996,000.00
- Revenue This Year
- LNW $8.75
- GH $19.53
- Revenue Next Year
- LNW $6.40
- GH $21.92
- P/E Ratio
- LNW $21.82
- GH N/A
- Revenue Growth
- LNW 7.30
- GH 28.20
- 52 Week Low
- LNW $75.46
- GH $18.01
- 52 Week High
- LNW $115.00
- GH $52.92
- Technical
- Relative Strength Index (RSI)
- LNW 41.44
- GH 43.79
- Support Level
- LNW $82.51
- GH $38.86
- Resistance Level
- LNW $95.15
- GH $52.92
- Average True Range (ATR)
- LNW 3.50
- GH 2.91
- MACD
- LNW 0.53
- GH -0.74
- Stochastic Oscillator
- LNW 25.64
- GH 20.34
About LNW Light & Wonder Inc.
Light & Wonder is principally an electronic gaming machine manufacturer, selling machines to pubs, clubs, and casinos. The firm is licensed in most jurisdictions allowing gambling globally. Light & Wonder is one of the three largest players in the space along with International Game Technology and Aristocrat Leisure. SciPlay, about one fourth of revenue, develops and distributes casual mobile games, principally in the social casino niche. The more nascent iGaming business sits between these two businesses, providing digital content and capabilities to real-money gaming providers.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.